Home/Pipeline/TBI Treatment System

TBI Treatment System

Traumatic Brain Injury

Development/TestingActive

Key Facts

Indication

Traumatic Brain Injury

Phase

Development/Testing

Status

Active

Company

Vivonics

About Vivonics

Vivonics is a private, R&D-focused medical technology firm leveraging a multidisciplinary engineering team and a strong network of clinical and military collaborators to develop advanced health monitoring and intervention systems. The company has a clear dual-track focus, securing significant non-dilutive funding from U.S. Department of Defense agencies and the NIH for military performance and casualty care applications, while also pursuing commercial clinical pathways in areas like vestibular stimulation and diabetic care. Its business model appears centered on government R&D contracts and grants to de-risk technology development, with the aim of ultimately commercializing products for broader healthcare markets.

View full company profile

Therapeutic Areas

Traumatic Brain Injury Vestibular Disorders Diabetic Neuropathy Combat Casualty Care Congenital Heart Disease

Other Traumatic Brain Injury Drugs

Drug	Company	Phase	Status
Presendin™ (Exenatide)	Invex Therapeutics	Preclinical	Active
TBI Modeling Platform	bmseed	Research Tool	Active
TV-301	TheraVac Biologics	Preclinical	Active
TBI Indication	Hera Health Solutions	Proof of Concept/Bench Validation	Active
NA-731	Biomed	Phase 2A	Active
Fv-Hsp72 for TBI	Rubicon Biotechnology	Pre-clinical	Active
Traumatic Brain Injury (TBI) Implant	Matricelf	Preclinical	Active